brimindinvest.com / compare / afl-vs-metLIVE
AFL
Aflac Incorporated · Financials
$115.47
-2.48% this month
VERSUS
COMPARE
MET
MetLife, Inc. · Financials
$85.58
+5.56% this month
Scoreboard verdict
Across AI score, momentum, valuation, upside, operating margin
AFL
3
MET
2
AFL LEADS 3/5
Comparison scoreboard
AFL LEADS 3/5
AI Score
AFL 49.3
MET 47.7
1Y Return
AFL +13.11%
MET +9.93%
Fwd P/E
AFL 15.49
MET 8.08
Target Up.
AFL -4.56%
MET +3.56%
Op. Margin
AFL 29.57%
MET 9.92%
Metrics last refreshed: 6/20/2026
Quick take

AFL vs MET Stock Comparison: AI Score, Valuation, Performance and Upside

Aflac and MetLife are both large insurance companies focused on workplace benefits and international markets, but their products and competitive positions differ materially. Aflac is the pure-play supplemental health insurer with unmatched Japan franchise value and an exceptional dividend track record. MetLife is a broader group benefits conglomerate with US large employer relationships and international diversification beyond Japan.

Aflac suits income investors who want a dividend compounder with a unique Japan supplemental health insurance franchise; MetLife suits those who prefer broader group benefits and international diversification with a lower Japan concentration.

Live analysis · updated 6/20/2026

AFL holds the edge across 3 of 5 key metrics in this comparison. AFL has delivered stronger 1-year price return (+13.11% vs +9.93%), though MET trades at the lower forward P/E (8.08x vs 15.49x). AFL leads on both revenue growth (27.90%) and operating margin (29.57%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for MET (+3.56%) than for AFL (-4.56%).

Normalized 1Y performance
AFL
MET
Recent returns
AFL
MET
Analyst price targets & sentiment
AFL
Price target range
analyst mean$112.43
current price$115.47
-4.6% upside to analyst mean
MET
Price target range
analyst mean$92.00
current price$85.58
+3.6% upside to analyst mean
Who should consider this stock?
AFL may suit investors who:
  • prioritize dividend income with 40+ consecutive years of annual increases
  • want unique exposure to supplemental health insurance in both the US and Japan markets
  • value a simple, focused business model with predictable claims and premium growth
  • are comfortable with yen/USD exchange rate sensitivity on Japan earnings
MET may suit investors who:
  • prefer broader insurance exposure across group life, disability, dental, and international
  • value the large US employer relationship base in the group benefits segment
  • want international emerging market insurance growth via Latin America and Asia
  • are comfortable with some mortality and interest rate volatility in a diversified insurer
Performance & AI score
MetricAFLMET
AI score49.347.7
AI rank#515#594
Latest close$115.47$85.58
1M return-2.48%+5.56%
6M return+4.50%+3.70%
1Y return+13.11%+9.93%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

PeriodAFLMET
1Y ago$11.25K (+12.5%)
started 2025-06-18
$10.89K (+8.9%)
started 2025-06-18
5Y ago$25.99K (+159.9%)
started 2021-06-21
$18.46K (+84.6%)
started 2021-06-21
10Y ago$51.02K (+410.2%)
started 2016-06-20
$43.9K (+339.0%)
started 2016-06-20

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
MetricAFLMET
Market cap$59.96B$57.16B
Trailing P/E13.4617.18
Forward P/E15.498.08
Price/SalesN/AN/A
EV/Revenue3.651.02
Analyst target$112.43$92.00
Target upside-4.56%+3.56%
Growth, profitability & risk
MetricAFLMET
Revenue growth27.90%2.70%
Earnings growth3860.00%35.90%
EPS growth+3860.00%+35.90%
FCF margin+27.18%-22.47%
Operating margin29.57%9.92%
Profit margin25.60%4.67%
ROIC proxy16.47%13.01%
Return on equity16.47%13.01%
Dividend yield2.07%2.67%
Beta0.610.78
Debt/equity48.28178.02
Current ratio0.942.09
Quick ratio0.811.75
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
AFL max drawdown9.59%
MET max drawdown18.33%
AFL max wkly drop5.11%
MET max wkly drop8.89%
5Y risk snapshot
AFL max drawdown19.86%
MET max drawdown35.09%
AFL max wkly drop11.28%
MET max wkly drop16.59%
10Y risk snapshot
AFL max drawdown54.89%
MET max drawdown55.16%
AFL max wkly drop31.59%
MET max wkly drop30.33%
Performance metrics by period
PeriodMetricAFLMET
1YGrowth+12.51%+8.95%
CAGR+12.53%+8.96%
Sharpe ratio0.510.29
Max drawdown9.59%18.33%
Max daily drop3.37%5.10%
Max wkly drop5.11%8.89%
5YGrowth+137.41%+62.12%
CAGR+18.91%+10.16%
Sharpe ratio0.720.33
Max drawdown19.86%35.09%
Max daily drop9.65%9.01%
Max wkly drop11.28%16.59%
10YGrowth+306.47%+207.21%
CAGR+15.06%+11.88%
Sharpe ratio0.500.38
Max drawdown54.89%55.16%
Max daily drop16.43%16.64%
Max wkly drop31.59%30.33%
Business comparison
CategoryAFLMET
CompanyAflac IncorporatedMetLife, Inc.
SectorFinancial ServicesFinancial Services
IndustryN/AN/A
Core businessAflac is the leading provider of supplemental health insurance in the US and Japan. Its products — which pay cash directly to policyholders for lost income during illness or injury — are sold primarily through workplaces in the US and through Japan Post and affiliated channels in Japan. Japan accounts for approximately 70% of pretax earnings, making currency exposure and Japanese consumer behavior key revenue drivers. The Aflac duck marketing campaigns have made it one of the most recognized insurance brands in the US.MetLife is one of the largest global insurance and employee benefits companies, offering group life, disability, dental, accident and health, and individual life products. Following the spin-off of its US retail life operations (Brighthouse Financial), MetLife has pivoted to group benefits and international insurance as its core businesses. The Group Benefits segment serves large US employers; international operations span Asia, Latin America, and the Middle East.
Investor focusInvestors track Japan premium revenue in USD terms (exposed to yen depreciation), US sales growth through new employer relationships, medical claims ratios, and the company's consistent dividend increase track record (40+ consecutive years).Investors track group benefits earnings (employer-paid premiums and claims experience), international growth rates by region, adjusted earnings per share excluding market movements, and capital return via dividends and buybacks.
AFL strengths
  • Dominant position in Japan supplemental health insurance with embedded Japan Post distribution
  • 40+ consecutive years of dividend increases, placing it among the highest-quality income stocks
  • Supplemental health insurance product demand is structurally growing as out-of-pocket healthcare costs rise
MET strengths
  • Leading US group benefits franchise serving the Fortune 500 with strong employer retention rates
  • International diversification across high-growth markets in Asia and Latin America
  • Spin-off of Brighthouse simplified the business and reduced equity market earnings volatility
Risks to watch — AFL
  • Japan revenue is sensitive to yen/USD exchange rate — yen weakness reduces USD reported earnings
  • Japan is a maturing market with demographic headwinds limiting long-term premium volume growth
  • US sales growth has been below historical rates in recent years
Risks to watch — MET
  • Group life mortality experience can be volatile — pandemic-era COVID losses illustrated this risk
  • Interest rate sensitivity in the investment portfolio as duration mismatches affect book value
  • International operations in emerging markets carry FX and political risk
Frequently asked questions
Aflac is the stronger dividend income compounder with a unique and defensible Japan supplemental insurance franchise that has produced exceptional long-term shareholder returns. MetLife offers broader diversification and potentially lower Japan concentration risk, but Aflac's earnings quality and dividend track record make it the preferred long-term holding for most income investors.
AI Prediction SignalNext 5 trading days
Members only
AFL
+2.8%BUY
MET
+1.1%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

Related comparisons
More comparisons
Browse all 1,000 comparisons →